Long, J. M. & Holtzman, D. M. Alzheimer disease: an update on pathobiology and treatment strategies. Cell 179, 312–339 (2019).
Google Scholar
van Dyck, C. H. et al. Lecanemab in early Alzheimer’s disease. N. Engl. J. Med 388, 9–21 (2023).
Google Scholar
Largent, E. A., Peterson, A. & Lynch, H. F. FDA drug approval and the ethics of desperation. JAMA Intern. Med. 181, 1555–1556 (2021).
Google Scholar
Caselli, R. J., Beach, T. G., Knopman, D. S. & Graff-Radford, N. R. Alzheimer disease: scientific breakthroughs and translational challenges. Mayo Clin. Proc. 92, 978–994 (2017).
Google Scholar
Pini, L. et al. Brain atrophy in Alzheimer’s disease and aging. Ageing Res. Rev. 30, 25–48 (2016).
Google Scholar
Zahs, K. R. & Ashe, K. H. ‘Too much good news’ – are Alzheimer mouse models trying to tell us how to prevent, not cure, Alzheimer’s disease?. Trends Neurosci. 33, 381–389 (2010).
Google Scholar
Gotz, J., Bodea, L. G. & Goedert, M. Rodent models for Alzheimer disease. Nat. Rev. Neurosci. 19, 583–598 (2018).
Google Scholar
Balusu, S. et al. MEG3 activates necroptosis in human neuron xenografts modeling Alzheimer’s disease. Science 381, 1176–1182 (2023).
Google Scholar
King, A. The search for better animal models of Alzheimer’s disease. Nature 559, S13–S15 (2018).
Google Scholar
Jawhar, S., Trawicka, A., Jenneckens, C., Bayer, T. A. & Wirths, O. Motor deficits, neuron loss, and reduced anxiety coinciding with axonal degeneration and intraneuronal Abeta aggregation in the 5XFAD mouse model of Alzheimer’s disease. Neurobiol. Aging 33, 196 e129–140 (2012).
Google Scholar
Herrup, K. & Yang, Y. Cell cycle regulation in the postmitotic neuron: oxymoron or new biology? Nat. Rev. Neurosci. 8, 368–378 (2007).
Google Scholar
Nagy, Z., Esiri, M. M., Cato, A. M. & Smith, A. D. Cell cycle markers in the hippocampus in Alzheimer’s disease. Acta Neuropathol. 94, 6–15 (1997).
Google Scholar
Yang, Y., Geldmacher, D. S. & Herrup, K. DNA replication precedes neuronal cell death in Alzheimer’s disease. J. Neurosci. 21, 2661–2668 (2001).
Google Scholar
Hochegger, H., Takeda, S. & Hunt, T. Cyclin-dependent kinases and cell-cycle transitions: does one fit all?. Nat. Rev. Mol. Cell Biol. 9, 910–U926 (2008).
Google Scholar
Welch, P. J. & Wang, J. Y. A C-terminal protein-binding domain in the retinoblastoma protein regulates nuclear c-Abl tyrosine kinase in the cell cycle. Cell 75, 779–790 (1993).
Google Scholar
Ren, S. J. & Rollins, B. J. Cyclin C/Cdk3 promotes Rb-dependent G0 exit. Cell 117, 239–251 (2004).
Google Scholar
Braun, K. et al. Investigation of the cell cycle regulation of cdk3-associated kinase activity and the role of cdk3 in proliferation and transformation. Oncogene 17, 2259–2269 (1998).
Google Scholar
Hofmann, F. & Livingston, D. M. Differential effects of cdk2 and cdk3 on the control of pRb and E2F function during G1 exit. Genes Dev. 10, 851–861 (1996).
Google Scholar
Ye, X., Zhu, C. & Harper, J. W. A premature-termination mutation in the Mus musculus cyclin-dependent kinase 3 gene. Proc. Natl Acad. Sci. USA 98, 1682–1686 (2001).
Google Scholar
Dragatsis, I. & Zeitlin, S. CaMKIIalpha-Cre transgene expression and recombination patterns in the mouse brain. Genesis 26, 133–135 (2000).
Google Scholar
Radde, R. et al. Abeta42-driven cerebral amyloidosis in transgenic mice reveals early and robust pathology. EMBO Rep. 7, 940–946 (2006).
Google Scholar
Yoshiyama, Y. et al. Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model. Neuron 53, 337–351 (2007).
Google Scholar
Lu, T. et al. Gene regulation and DNA damage in the ageing human brain. Nature 429, 883–891 (2004).
Google Scholar
Zhang, B. et al. Integrated systems approach identifies genetic nodes and networks in late-onset Alzheimer’s disease. Cell 153, 707–720 (2013).
Google Scholar
Zhou, Y. et al. Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2-independent cellular responses in Alzheimer’s disease. Nat. Med 26, 131–142 (2020).
Google Scholar
Bai, B. et al. Deep multilayer brain proteomics identifies molecular networks in Alzheimer’s disease progression. Neuron 106, 700 (2020).
Google Scholar
Waterhouse, A. et al. SWISS-MODEL: homology modelling of protein structures and complexes. Nucleic Acids Res. 46, W296–W303 (2018).
Google Scholar
Tang, X. Y. et al. DSCAM/PAK1 pathway suppression reverses neurogenesis deficits in iPSC-derived cerebral organoids from patients with Down syndrome. J. Clin. Invest. 131, 1–16 (2021).
Google Scholar
Gui, W. et al. Structural basis of CDK3 activation by cyclin E1 and inhibition by dinaciclib. Biochem. Biophys. Res. Commun. 662, 126–134 (2023).
Google Scholar
Ren, S. & Rollins, B. J. Cyclin C/cdk3 promotes Rb-dependent G0 exit. Cell 117, 239–251 (2004).
Google Scholar
Fleisher, A. S. et al. Volumetric MRI vs clinical predictors of Alzheimer disease in mild cognitive impairment. Neurology 70, 191–199 (2008).
Google Scholar
Teipel, S. J. et al. Relevance of magnetic resonance imaging for early detection and diagnosis of Alzheimer disease. Med. Clin. North Am. 97, 399–424 (2013).
Google Scholar
Iqbal, K., Liu, F., Gong, C. X. & Grundke-Iqbal, I. Tau in Alzheimer disease and related tauopathies. Curr. Alzheimer Res. 7, 656–664 (2010).
Google Scholar
Bloom, G. S. Amyloid-beta and tau: the trigger and bullet in Alzheimer disease pathogenesis. JAMA Neurol. 71, 505–508 (2014).
Google Scholar
Goedert, M., Spillantini, M. G., Cairns, N. J. & Crowther, R. A. Tau proteins of Alzheimer paired helical filaments: abnormal phosphorylation of all six brain isoforms. Neuron 8, 159–168 (1992).
Google Scholar
Spillantini, M. G., Crowther, R. A., Kamphorst, W., Heutink, P. & van Swieten, J. C. Tau pathology in two Dutch families with mutations in the microtubule-binding region of tau. Am. J. Pathol. 153, 1359–1363 (1998).
Google Scholar
Fujita, K. et al. Targeting Tyro3 ameliorates a model of PGRN-mutant FTLD-TDP via tau-mediated synaptic pathology. Nat. Commun. 9, 433 (2018).
Google Scholar
Saito, T. et al. Cdk5 increases MARK4 activity and augments pathological tau accumulation and toxicity through tau phosphorylation at Ser262. Hum. Mol. Genet. 28, 3062–3071 (2019).
Google Scholar
Noble, W. et al. Cdk5 is a key factor in tau aggregation and tangle formation in vivo. Neuron 38, 555–565 (2003).
Google Scholar
Zhang, W., Chen, H., Qu, X., Chang, C. P. & Shou, W. Molecular mechanism of ventricular trabeculation/compaction and the pathogenesis of the left ventricular noncompaction cardiomyopathy (LVNC). Am. J. Med. Genet. C 163C, 144–156 (2013).
Google Scholar
Fang, X. et al. Loss of cardiac ferritin H facilitates cardiomyopathy via Slc7a11-mediated ferroptosis. Circ. Res. 127, 486–501 (2020).
Google Scholar
Kovács, G. G. et al. Genetic prion disease: the EUROCJD experience. Hum. Genet. 118, 166–174 (2005).
Google Scholar
Singh, S., Vanden Broeck, A., Miller, L., Chaker-Margot, M. & Klinge, S. Nucleolar maturation of the human small subunit processome. Science 373, 1–13 (2021).
Google Scholar
Okuno, Y., McNairn, A. J., den Elzen, N., Pines, J. & Gilbert, D. M. Stability, chromatin association and functional activity of mammalian pre-replication complex proteins during the cell cycle. EMBO J. 20, 4263–4277 (2001).
Google Scholar
Tang, H. et al. MDM2 is implicated in high-glucose-induced podocyte mitotic catastrophe via Notch1 signalling. J. Cell. Mol. Med. 21, 3435–3444 (2017).
Google Scholar
Taipale, M. et al. Chaperones as thermodynamic sensors of drug-target interactions reveal kinase inhibitor specificities in living cells. Nat. Biotechnol. 31, 630–637 (2013).
Google Scholar
Wood, D. J. & Endicott, J. A. Structural insights into the functional diversity of the CDK-cyclin family. Open Biol. 8, 1–26 (2018).
Google Scholar
Christensen, C. L. et al. Targeting transcriptional addictions in small cell lung cancer with a covalent CDK7 inhibitor. Cancer Cell 26, 909–922 (2014).
Google Scholar
Sanso, M. et al. Cdk9 and H2Bub1 signal to Clr6-CII/Rpd3S to suppress aberrant antisense transcription. Nucleic Acids Res. 48, 7154–7168 (2020).
Google Scholar
Paparidis, N. F., Durvale, M. C. & Canduri, F. The emerging picture of CDK9/P-TEFb: more than 20 years of advances since PITALRE. Mol. Biosyst. 13, 246–276 (2017).
Google Scholar
Zhang, L., Fried, F. B., Guo, H. & Friedman, A. D. Cyclin-dependent kinase phosphorylation of RUNX1/AML1 on 3 sites increases transactivation potency and stimulates cell proliferation. Blood 111, 1193–1200 (2008).
Google Scholar
Cummings, J. et al. Alzheimer’s disease drug development pipeline: 2023. Alzheimers Dement. 9, e12385 (2023).
Games, D. et al. Alzheimer-type neuropathology in transgenic mice overexpressing V717f beta-amyloid precursor protein. Nature 373, 523–527 (1995).
Google Scholar
Schmitz, C. et al. Hippocampal neuron loss exceeds amyloid plaque load in a transgenic mouse model of Alzheimer’s disease. Am. J. Pathol. 164, 1495–1502 (2004).
Google Scholar
Liachko, N. F. et al. CDC7 inhibition blocks pathological TDP-43 phosphorylation and neurodegeneration. Ann. Neurol. 74, 39–52 (2013).
Google Scholar
Shackelford, R. E. et al. The Ataxia telangiectasia gene product is required for oxidative stress-induced G1 and G2 checkpoint function in human fibroblasts. J. Biol. Chem. 276, 21951–21959 (2001).
Google Scholar
Hoglinger, G. U. et al. The pRb/E2F cell-cycle pathway mediates cell death in Parkinson’s disease. Proc. Natl Acad. Sci. USA 104, 3585–3590 (2007).
Google Scholar
Sun, X. et al. PANoptosis: mechanisms, biology, and role in disease. Immunol. Rev. 321, 246–262 (2024).
Google Scholar
Teo, T. et al. An overview of CDK3 in cancer: clinical significance and pharmacological implications. Pharmacol. Res. 180, 1–15 (2022).
Google Scholar
Herrup, K. Post-mitotic role of the cell cycle machinery. Curr. Opin. Cell Biol. 25, 711–716 (2013).
Google Scholar
Betz, U. A. K., Voßhenrich, C. A. J., Rajewsky, K. & Müller, W. Bypass of lethality with mosaic mice generated by Cre–loxP-mediated recombination. Curr. Biol. 6, 1307–1316 (1996).
Google Scholar
Yuan, J. et al. Two conserved epigenetic regulators prevent healthy ageing. Nature 579, 118–122 (2020).
Google Scholar
Caccamo, A. et al. Necroptosis activation in Alzheimer’s disease. Nat. Neurosci. 20, 1236–1246 (2017).
Google Scholar
